COMMUNIQUÉS West-GlobeNewswire

dacadoo Launches Generation 5 of Its Award-Winning Digital Health Engagement Platform
27/05/2025
Zurich, CH, May 27, 2025 (GLOBE NEWSWIRE) -- dacadoo, a global leader in digital health engagement technology since 2010 with over 100 granted patents, announces the launch of Generation 5 of its Digital Health [...]
Epitopea annonce un article dans Nature Cancer sur de nouvelles cibles d'immunothérapie dans le mélanome et le cancer du poumon non à petites cellules (NSCLC)
27/05/2025
Validation supplémentaire des Cryptigens™ en tant que cibles exploitables pour l'immunothérapie du cancer MONTRÉAL et CAMBRIDGE, Royaume-Uni, 27 mai 2025 (GLOBE NEWSWIRE) -- Epitopea, une société transatlantique [...]
Epitopea Announces Nature Cancer Paper on Novel Immunotherapy Targets in Melanoma and NSCLC
27/05/2025
Further Validates Cryptigens™ as Actionable Targets for Cancer Immunotherapy MONTREAL and CAMBRIDGE, United Kingdom, May 27, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapy company, and Institute [...]
ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds
27/05/2025
Debt capital to support commercial readiness and potential U.S. launch of n.c.a. 177 Lu-edotreotide (ITM-11), following positive Phase 3 results Flexible funding structure enables continued advancement of ITM’s targeted [...]
Communiqué de presse : Sanofi finalise l’acquisition du DR-0201
27/05/2025
Sanofi finalise l’acquisition du DR-0201 Paris, le 27 mars 2025. Sanofi annonce la finalisation de l’acquisition du DR-0201, un anticorps bispécifique ciblé qui engage les cellules myéloïdes, à Dren Bio, Inc., société [...]
Press Release: Sanofi completes acquisition of DR-0201
27/05/2025
Sanofi completes acquisition of DR-0201 Paris, May 27, 2025. Sanofi announces the completion of its acquisition of DR-0201 , a targeted bispecific myeloid cell engager, from Dren Bio, Inc., a private clinical-stage [...]
Press release: Sequana Medical Secures Additional Convertible Financing of EUR 6.3 Million from SFPIM and Other Existing Shareholders
27/05/2025
Sequana Medical Secures Additional Convertible Financing of EUR 6.3 Million from SFPIM and Other Existing Shareholders Continued strong support from major shareholders alfapump® US commercial launch remains on track for [...]
Vivoryon Therapeutics N.V. Expands Intellectual Property Portfolio with New U.S. Composition of Matter Patent Granted for Varoglutamstat
27/05/2025
Vivoryon Therapeutics N.V. Expands Intellectual Property Portfolio with New U.S. Composition of Matter Patent Granted for Varoglutamstat Newly granted U.S. patent expected to provide exclusivity through 2044 with [...]
Augustine Therapeutics announces first patient dosed in Phase I clinical trial evaluating lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth disease
27/05/2025
AGT-100216 is the first HDAC6 inhibitor from Augustine’s pipeline to enter clinical trials LEUVEN, Belgium – 27 May 2025 – Augustine Therapeutics NV (“Augustine” or “the Company”), a biotechnology company focused on [...]
Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025, alors que NCX 470 se prépare à entrer en essais cliniques de Phase 3 au Japon
27/05/2025
Communiqué de presse Nicox annonce jusqu’à 3 millions d’euros de paiements d’étapes de la part de Kowa en 2025, alors que NCX 470 se prépare à entrer en essais cliniques de Phase 3 au Japon Kowa, le partenaire exclusif [...]
Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 Clinical Trials in Japan
27/05/2025
Press Release Nicox Announces up to €3 million in Milestone Payments from Kowa in 2025 as NCX 470 Prepares to Enter Phase 3 Clinical Trials in Japan Exclusive Japanese partner Kowa has received regulatory approval to [...]
CROSSJECT met en place un nouveau module de fabrication pour augmenter la polyvalence et la capacité de la ZENEO® Factory en prévision du déploiement de l'ensemble de son portefeuille de produits
27/05/2025
Communiqué de presse CROSSJECT met en place un nouveau module de fabrication pour augmenter la polyvalence et la capacité de la ZENEO® Factory en prévision du déploiement de l'ensemble de son portefeuille de produits [...]
CROSSJECT implements new manufacturing module to scale-up the ZENEO® Factory ‘s versatility and capacity in anticipation of full product pipeline deployment
27/05/2025
Press release CROSSJECT implements new manufacturing module to scale-up the ZENEO® Factory ‘s versatility and capacity in anticipation of full product pipeline deployment CROSSJECT developed the ZENEO® Nest , a new [...]
Premier Health Announces CFO Transition
26/05/2025
MONTRÉAL, May 26, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA ) (the “ Corporation ”), a leading Canadian Healthtech company, announces today that it is proceeding with a transition of the CFO [...]
ARCPOINT REPORTS Q1 2025 FINANCIAL RESULTS
27/05/2025
Greenville, South Carolina, May 26, 2025 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to report that it has filed its unaudited Q1, 2025 Financial Statements and related [...]
IBA – ACQUISITION D’ACTIONS PROPRES
26/05/2025
Publication immédiate – 26 mai 2025 Louvain-la-Neuve, Belgique, 26 mai 2025 - Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam [...]
Iba – Acquisition of Own Shares
26/05/2025
Immediate Release – May 26 th , 2025 Louvain-la-Neuve, Belgium, May 26 th , 2025 - In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam [...]
Alvotech Annual General Meeting to be held June 25, 2025
26/05/2025
The Annual General Meeting of Alvotech will be held on Wednesday June 25, 2025, at 09.00 a.m. CEST at the premises of Arendt & Medernach at 41A, Avenue John F. Kennedy L-1855 Luxembourg, Grand Duchy of Luxembourg. [...]
Liv Hospital and Istinye University Announce Groundbreaking Academic Collaboration with University of Pennsylvania’s Perelman School of Medicine
26/05/2025
ISTANBUL, May 26, 2025 (GLOBE NEWSWIRE) -- Liv Hospital and Istinye University have signed a comprehensive collaboration protocol with the University of Pennsylvania’s Perelman School of Medicine to advance cutting-edge [...]

Pages